Literature DB >> 4038490

Phenylalanine ammonia-lyase immobilized in semipermeable microcapsules for enzyme replacement in phenylketonuria.

L Bourget, T M Chang.   

Abstract

Phenylalanine ammonia-lyase immobilized within semipermeable microcapsules has an assayed enzyme activity which is 20% +/- 4% of the enzyme in free solution. The Km for the immobilized enzyme remained the same as that of the free enzyme. The pH optimum also remained unchanged at pH 8.5 +/- 1.0. At the lower pH range, enzyme activity is higher for the immobilized enzyme. Daily oral administration of microencapsulated phenylalanine ammonia-lyase to phenylketonuric rats decreased the systemic phenylalanine level by 35 +/- 8% in 2 days (P less than 0.05) and by 75 +/- 8% in 7 days (P less than 0.001).

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4038490     DOI: 10.1016/0014-5793(85)80219-2

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  5 in total

Review 1.  Enzyme-replacement therapy: problems and prospects.

Authors:  B Rademaker; J Raber
Journal:  Pharm Weekbl Sci       Date:  1989-10-20

2.  Clinical therapeutics for phenylketonuria.

Authors:  Jaspreet Singh Kochhar; Sui Yung Chan; Pei Shi Ong; Lifeng Kang
Journal:  Drug Deliv Transl Res       Date:  2012-08       Impact factor: 4.617

3.  Immobilization of Phenylalanine Ammonia-Lyase on Single-Walled Carbon Nanotubes for Stereoselective Biotransformations in Batch and Continuous-Flow Modes.

Authors:  Judith H Bartha-Vári; Monica I Toşa; Florin-Dan Irimie; Diána Weiser; Zoltán Boros; Beáta G Vértessy; Csaba Paizs; László Poppe
Journal:  ChemCatChem       Date:  2015-03-12       Impact factor: 5.686

4.  A microparticulate based formulation to protect therapeutic enzymes from proteolytic digestion: phenylalanine ammonia lyase as case study.

Authors:  Irene Pereira de Sousa; Charlotte Gourmel; Olena Berkovska; Michael Burger; Jean-Christophe Leroux
Journal:  Sci Rep       Date:  2020-02-27       Impact factor: 4.379

5.  Cell encapsulation as a potential nondietary therapy for maternal phenylketonuria.

Authors:  Donna A Santillan; Mark K Santillan; Stephen K Hunter
Journal:  Am J Obstet Gynecol       Date:  2009-07-24       Impact factor: 8.661

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.